Results 231 to 240 of about 164,128 (338)

Thyroxine-Metabolizing Rat Uridine Diphosphate-Glucuronosyltransferase 1A7 Is Regulated by Thyroid Hormone Receptor [PDF]

, 2007
Yoshikazu Emi, Shinichi Ikushiro, Yoshihisa Kato   +2 more
openalex   +1 more source

Assessment and treatment of patients with hypothyroidism [PDF]

, 2009
Carson, M. N.
core  

Influence af acute iodine incorporation on thyroid function and thyroidal iodine content [PDF]

, 1981
Habermann, J., Leisner, B., Pickardt, C. R., Scriba, Peter Christian, Witte, A.   +4 more
core   +1 more source

Association Between Arterial Stiffness and Bone Microarchitectural Deterioration in Type 2 Diabetes: A Cross‐Sectional Study

Journal of Diabetes, Volume 17, Issue 12, December 2025.
Identified baPWV as a novel independent influencing factor of bone microarchitecture deterioration in T2DM, elucidating a bone–vascular axis. Proposes baPWV as a practical indicator for simultaneous cardiovascular and fracture risk assessment in diabetic patients.
Yangting Wang, Xiaoting Chen, Jinjian Xu, Qifeng Ying, Lizhi Liang, Xiaohong Wu   +5 more
wiley   +1 more source

Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis.

New England Journal of Medicine, 2006
M. Centanni, L. Gargano, G. Canettieri, N. Viceconti, A. Franchi, G. delle Fave, B. Annibale   +6 more
semanticscholar   +1 more source

The Effect of Thyroid Function on GDF15 Levels. [PDF]

Int J Mol Sci
Profili NI, Fiorillo E, Orrù V, Cucca F, Delitala AP.   +4 more
europepmc   +1 more source

External quality-control surveys of peptide hormone radioimmunoassays in the Federal Republic of Germany : The present status [PDF]

, 1978
Breuer, H., Jungbluth, D., Marschner, I., Röhle, G., Scriba, Peter Christian, Wood, W. G.   +5 more
core   +1 more source

Effects of Resmetirom on Metabolic‐Dysfunction Associated Steatohepatitis in Patients With Weight Loss and/or Diabetes Taking Glucagon‐Like Peptide‐1 Receptor Agonists and Other Diabetes Therapies: A Secondary Analysis of the MAESTRO‐NASH Trial

Alimentary Pharmacology &Therapeutics, Volume 62, Issue 11-12, Page 1089-1099, December 2025.
This secondary analysis of the MAESTRO‐NASH trial examined the effects of resmetirom in patients with weight loss and/or treated with therapies for T2D. The efficacy of resmetirom was not impacted by background T2DM therapies. Weight loss (≥ 5%) enhanced the effect of resmetirom on multiple MASH endpoints. ABSTRACT Background MAESTRO‐NASH, a randomised,
Mazen Noureddin, Mary Rinella, Rebecca Taub, Dominic Labriola, Raul C. Camacho, Naim Alkhouri, Rohit Loomba, Meena B. Bansal   +7 more
wiley   +1 more source

Addressing the hypothyroidism impasse - seeking a consensus for the treatment of dissatisfied hypothyroid patients. [PDF]

Front Endocrinol (Lausanne)
Welborn T.
europepmc   +1 more source

Peripheral artery disease is not a risk factor of major adverse cardiovascular events in thyroxine using diabetic patients: a retrospective study [PDF]

Chih‐Wei Hsu, Chia-Hung Lin, Pi‐Hua Liu, Yi‐Hsuan Lin   +3 more
openalex   +1 more source